167 related articles for article (PubMed ID: 26030442)
1. Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.
Shlensky D; Mirrielees JA; Zhao Z; Wang L; Mahajan A; Yu M; Sherer NM; Wilke LG; Xu W
PLoS One; 2015; 10(6):e0128143. PubMed ID: 26030442
[TBL] [Abstract][Full Text] [Related]
2. CARM1 automethylation is controlled at the level of alternative splicing.
Wang L; Charoensuksai P; Watson NJ; Wang X; Zhao Z; Coriano CG; Kerr LR; Xu W
Nucleic Acids Res; 2013 Aug; 41(14):6870-80. PubMed ID: 23723242
[TBL] [Abstract][Full Text] [Related]
3. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
4. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
[TBL] [Abstract][Full Text] [Related]
5. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
[TBL] [Abstract][Full Text] [Related]
6. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
7. Coactivator-associated arginine methyltransferase 1, CARM1, affects pre-mRNA splicing in an isoform-specific manner.
Ohkura N; Takahashi M; Yaguchi H; Nagamura Y; Tsukada T
J Biol Chem; 2005 Aug; 280(32):28927-35. PubMed ID: 15944154
[TBL] [Abstract][Full Text] [Related]
8. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1 (CARM1), is associated with specific breast cancer subtypes and ethnicity.
Davis MB; Liu X; Wang S; Reeves J; Khramtsov A; Huo D; Olopade OI
Mol Cancer; 2013 May; 12(1):40. PubMed ID: 23663560
[TBL] [Abstract][Full Text] [Related]
9. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
Habashy HO; Rakha EA; Ellis IO; Powe DG
Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
[TBL] [Abstract][Full Text] [Related]
10. LSD1 engages a corepressor complex for the activation of the estrogen receptor α by estrogen and cAMP.
Bennesch MA; Segala G; Wider D; Picard D
Nucleic Acids Res; 2016 Oct; 44(18):8655-8670. PubMed ID: 27325688
[TBL] [Abstract][Full Text] [Related]
11. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene.
El Messaoudi S; Fabbrizio E; Rodriguez C; Chuchana P; Fauquier L; Cheng D; Theillet C; Vandel L; Bedford MT; Sardet C
Proc Natl Acad Sci U S A; 2006 Sep; 103(36):13351-6. PubMed ID: 16938873
[TBL] [Abstract][Full Text] [Related]
12. Involvement of arginine methyltransferase CARM1 in androgen receptor function and prostate cancer cell viability.
Majumder S; Liu Y; Ford OH; Mohler JL; Whang YE
Prostate; 2006 Sep; 66(12):1292-301. PubMed ID: 16705743
[TBL] [Abstract][Full Text] [Related]
13. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis.
Wang L; Zhao Z; Meyer MB; Saha S; Yu M; Guo A; Wisinski KB; Huang W; Cai W; Pike JW; Yuan M; Ahlquist P; Xu W
Cancer Cell; 2014 Jan; 25(1):21-36. PubMed ID: 24434208
[TBL] [Abstract][Full Text] [Related]
14. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing.
Cheng D; Côté J; Shaaban S; Bedford MT
Mol Cell; 2007 Jan; 25(1):71-83. PubMed ID: 17218272
[TBL] [Abstract][Full Text] [Related]
15. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.
Frietze S; Lupien M; Silver PA; Brown M
Cancer Res; 2008 Jan; 68(1):301-6. PubMed ID: 18172323
[TBL] [Abstract][Full Text] [Related]
16. TFEB, SIRT1, CARM1, Beclin-1 expression and PITX2 methylation in breast cancer chemoresistance: a retrospective study.
Bertozzi S; Londero AP; Viola L; Orsaria M; Bulfoni M; Marzinotto S; Corradetti B; Baccarani U; Cesselli D; Cedolini C; Mariuzzi L
BMC Cancer; 2021 Oct; 21(1):1118. PubMed ID: 34663249
[TBL] [Abstract][Full Text] [Related]
17. A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.
Cai XC; Zhang T; Kim EJ; Jiang M; Wang K; Wang J; Chen S; Zhang N; Wu H; Li F; Dela Seña CC; Zeng H; Vivcharuk V; Niu X; Zheng W; Lee JP; Chen Y; Barsyte D; Szewczyk M; Hajian T; Ibáñez G; Dong A; Dombrovski L; Zhang Z; Deng H; Min J; Arrowsmith CH; Mazutis L; Shi L; Vedadi M; Brown PJ; Xiang J; Qin LX; Xu W; Luo M
Elife; 2019 Oct; 8():. PubMed ID: 31657716
[TBL] [Abstract][Full Text] [Related]
18. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
[TBL] [Abstract][Full Text] [Related]
19. A CARM1 Inhibitor Potently Suppresses Breast Cancer Both In Vitro and In Vivo.
Peng BL; Ran T; Chen X; Ding JC; Wang ZR; Li WJ; Liu W
J Med Chem; 2024 May; 67(10):7921-7934. PubMed ID: 38713486
[TBL] [Abstract][Full Text] [Related]
20. CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator.
Suresh S; Huard S; Dubois T
Trends Cell Biol; 2021 May; 31(5):402-417. PubMed ID: 33485722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
